Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Burden of Breast Cancer in Iranian Women is Increasing

  • Published : 2015.07.13
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Breast cancer (BC) is the leading cause of oncological death for women, in both developed and developing countries. In Iran, breast cancer ranks first among cancers diagnosed in women. The aim of this study was to present the burden of this cancer including incidence, mortality and years life lost (YLL) due to breast cancer in Iranian women. Materials and Methods: National incidence data from the Iranian annual National Cancer Registration reports from 2003 to 2009 and national death statistics reported by the Ministry of Health and Medical Education from 1995 to 2010, stratified by age group, were included in this analysis. Also calculated YLLs provided by the Institute for Health Metrics and Evaluation (IHME) for the years 1990, 1995, 2000, 2005 and 2010 were employed to express the years lost due to BC for Iranian women. Results: The general mortality rate of breast cancer increased during these years from 0.96 to 4.33 per 100,000 and incidence increased from 16.0 to 28.3 per 100,000 for the years under study. YLLs calculated by IHME showed both increasing and decreasing patterns, with a tendency for stabilization. Conclusions: The burden of breast cancer for Iranian women is still increasing. Thus, health education programs to inform women regarding the signs and risk factors, and national screening to facilitate early diagnosis are needed for the female community in Iran.

Keywords

References

  1. Ademuyiwa FO, Gao F, Hao L, et al (2014). US breast cancer mortality trends in young women according to race. Cancer, 121, 1469-76
  2. Autier P, Boniol M, Gavin A, Vatten LJ (2011). Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ, 28, 343.
  3. Berry DA, Cronin KA, Plevritis SK, et al (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 353, 1784-92. https://doi.org/10.1056/NEJMoa050518
  4. Bosetti C, Bertuccio P, Levi F (2012). The decline in breast cancer mortality in Europe: an update (to 2009). Breast, 21, 77-82. https://doi.org/10.1016/j.breast.2011.08.001
  5. Bulliard JL, La Vecchia C, Levi F (2006). Diverging trends in breast cancer mortality within Switzerland. Ann Oncol, 7, 57-9.
  6. Burton R, Bell R (2013). The global challenge of reducing breast cancer mortality. Oncologist, 18, 1200-2. https://doi.org/10.1634/theoncologist.2013-0315
  7. Choi Y, Kim Y, Park SK, et al (2006). Age-period-cohort analysis of female breast cancer mortality in Korea. Breast Cancer, 13, 266-71. https://doi.org/10.2325/jbcs.13.266
  8. Corbex M, Burton R, Sancho-Garnier H (2012). Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast, 21, 428-34. https://doi.org/10.1016/j.breast.2012.01.002
  9. Elmore JG, Armstrong K, Lehman CD, Fletcher SW (2005). Screening for breast cancer. JAMA, 293, 1245-56. https://doi.org/10.1001/jama.293.10.1245
  10. Gorini G, Zappa M, Cortini B, et al (2014). Breast cancer mortality trends in Italy by region and screening programme, 1980-2008. J Med Screen, 21, 189-93. https://doi.org/10.1177/0969141314549368
  11. Haghighat S, Akbari ME, Ghaffari S, Yavari P (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8. https://doi.org/10.7314/APJCP.2012.13.11.5525
  12. He M, Guo Q, Hu G (2011). Reversed urban-rural differences in breast cancer mortality (China, 2002.2008). Breast Cancer Res Treat, 126, 231-4. https://doi.org/10.1007/s10549-010-1276-2
  13. Hery C, Ferlay JM, Boniol M, Autier P (2009). Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol, 19, 1187-94.
  14. Hoerger TJ, Ekwueme DU, Miller JW, et al (2011). Estimated effects of the national breast and cervical cancer early detection program on breast cancer mortality. Am J Prev Med, 40, 397-404. https://doi.org/10.1016/j.amepre.2010.12.017
  15. Hulka BS, Moorman PG (2008). Breast cancer: hormones and other risk factors. Maturitas, 61, 203-13. https://doi.org/10.1016/j.maturitas.2008.11.016
  16. Islamic Republic of Iran. Ministry of health and medical education. center for disease control & prevention. noncommunicable deputy. cancer office (2009). Iranian Annual of National Cancer Registration Report.
  17. Islamic Republic of Iran (2012). Ministry of health and medical education, center for network management, information technology and applied researches group center. Death report from 29 provinces in Iran from 2006 to 2010. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
  18. Institute for Health Metrics and Evaluation (IHME) (2014). Available at: http://www.healthdata.org/gbd
  19. Jafari-Koshki T, Schmid VJ, Mahaki B (2014). Trends of breast cancer incidence in Iran during 2004-2008: a Bayesian space-time model. Asian Pac J Cancer Prev, 15, 1557-61. https://doi.org/10.7314/APJCP.2014.15.4.1557
  20. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  21. Katanoda K, Yako-Suketomo H (2010). Comparison of time trends in breast cancer mortality (1990-2006) in the World, from the WHO mortality database. Jpn J Clin Oncol, 40, 182. https://doi.org/10.1093/jjco/hyq003
  22. Mandelblatt J, van Ravesteyn N, Schechter C, et al (2013). Which strategies reduce breast cancer mortality most? Collaborative modeling of optimal screening, treatment, and obesity prevention. Cancer, 119, 2541-8. https://doi.org/10.1002/cncr.28087
  23. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in tehran metropolis: the first report from the tehran population-based cancer registry, 1998-2001 Arch Iran Med, 12, 15-23.
  24. Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med, 7, 6. https://doi.org/10.1186/1447-056X-7-6
  25. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  26. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91. https://doi.org/10.1111/j.1524-4741.2007.00446.x
  27. Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, et al (2006). Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Asian Pac J Cancer Prev, 7, 571-4.
  28. Naghavi M (2002). Death report from 18 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
  29. Naghavi M (2003). Death report from 23 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
  30. Naghavi M (2004). Death report from 29 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
  31. Rahimzadeh M, Baghestani AR, Gohari MR, Pourhoseingholi MA (2014). Estimation of the cure rate in Iranian breast cancer patients. Asian Pac J Cancer Prev, 15, 4839-42. https://doi.org/10.7314/APJCP.2014.15.12.4839
  32. Sadjadi A, Nouraie M, Mohagheghi MA, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-63.
  33. Safaee A, Moghimi-Dehkordi B, Zeighami B, et al (2008). Predictors of quality of life in breast cancer patients under chemotherapy. Indian J Cancer, 45, 107-11. https://doi.org/10.4103/0019-509X.44066
  34. Sant M, Francisci S, Capocaccia R, et al (2006). Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer, 119, 2417-22. https://doi.org/10.1002/ijc.22160
  35. Taghavi A, Fazeli Z, Vahedi M, et al (2012). Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70. https://doi.org/10.7314/APJCP.2012.13.1.367
  36. Vilaprinyo E, Puig T, Rue M (2012). Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain. PLoS One, 7, 30157. https://doi.org/10.1371/journal.pone.0030157
  37. World Health Organization (2013). Cancer Control: Knowledge Into Action. "Early detection." Available at http://whqlibdoc.who.int/publications/2007/9241547338_eng.pdf. Accessed August 10,
  38. World Health Organization (2009). Mortality database. WHO, 2-6.
  39. Yavari P, Pourhoseingholi MA (2007). Socioeconomic factors association with knowledge and practice of breast self-examination among Iranian women. Asian Pac J Cancer Prev, 8, 618-22.

Cited by

  1. Shikonin Induced Necroptosis via Reactive Oxygen Species in the T-47D Breast Cancer Cell Line vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7261
  2. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8335
  3. Survival Rates for Breast Cancer in Iranian Patients: a Meta-Analysis vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.2223
  4. High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer vol.17, pp.4, 2017, https://doi.org/10.1007/s10238-016-0442-1
  5. An infodemiology study on breast cancer in Iran vol.36, pp.2, 2018, https://doi.org/10.1108/EL-03-2017-0062